"Mount Sinai CEO Discusses Lowering Drug Costs (Podcast)"
Kenneth Davis, MD, president and CEO of the Mount Sinai Health System discusses the issue of escalating drug costs. According to Dr. Davis, revision of patent laws would help promote truly innovative drugs, not copy-cat drugs.
— Kenneth L. Davis, MD, President, CEO, Mount Sinai Health System